ARTICLE | Clinical News

Genetics Institute, Amgen regulatory update

July 5, 1994 7:00 AM UTC

EPO, which stimulates the production of red blood cells, is sold in Europe under license from Cambridge-based GENIZ by Boehringer Mannheim GmbH. GENIZ received $7.5 million in revenues from Boehringer's 1993 sales. AMGN (Thousand Oaks, Calif.) doesn't break out its EPO royalties. ...